Sterne, Kessler, Goldstein & Fox P.L.L.C.
Polynucleotides encoding Notch receptor antibodies
The present invention relates to Notch-binding agents and Notch antagonists and methods of using the agents and/or antagonists for treating diseases such as cancer. The present invention provides antibodies that specifically bind to a non-ligand binding region of the extracellular domain of one or more human Notch receptor, such as Notch2 and/or Notch3, and inhibit tumor growth. The present invention further provides methods of treating cancer, the methods comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human Notch receptor protein and inhibits tumor growth.
OncoMed Pharmaceuticals, Inc.
C C C A C A C A A C A C C C A C C A C C C C C C A C C C C C C A A C
C07K C07K C07K A61K C12N A61K C07K A61N A61P C07K A61K C12N C07K C07K A61K C12N C07K A61P C07K C07K C07K C07K C07H C07K A61P C07K C07K C07K C07K C12N C12N A61P A61K C07K
additional additional inventional additional inventional inventional inventional inventional inventional additional inventional additional additional additional inventional additional additional inventional additional inventional additional additional additional additional inventional inventional inventional additional inventional additional additional inventional inventional additional
John A. Austin L. Yuan Ching Edward Thein Timothy Charles Maureen Fitch Aaron Ken
Lewicki Gurney Liu Htun van der Horst Hoey Bruhns Sato